Programm
Link to Registration: on-site and online
| Time (CEST) | Title |
| 08:45 | Welcoming introduction Scientific committee |
| Session 1 | Early detection, screening and MRD Chairs: Klaus Pantel | Hamburg, Nikolas von Bubnoff | Lübeck | |
| 09:00 | Liquid biopsy and minimal residual disease Catherine Alix-Panabières | Montpellier |
| 09:20 | Circulating tumor DNA based decision for adjuvant treatment in colon cancer stage II evaluation (CIRCULATE) AIO-KRK-0217 Gunnar Folprecht | Dresden |
| 09:40 | Use of ctDNA methylation signatures for early detection and MRD? Holger Sültmann | Heidelberg |
| 10:00 | Proteomics of liquid biopsies for cancer diagnosis, monitoring and prognosis Timo Gemoll | Lübeck |
| 10:20 | Wrap-up and closing remarks |
| 10:30 | Short Coffee BREAK |
| Parallel Session 2a | Non-invasive response monitoring and clonal evolution Chairs: Michael Forster | Kiel, Jens Höppner | Lübeck | |
| 10:50 | CTCs for monitoring treatment response and to unravel mechanisms of treatment resistance Sabine Riethdorf | Hamburg |
| 11:10 | CtDNA for early response monitoring Nikolas von Bubnoff | Lübeck |
| 11:30 | CtDNA for monitoring clonal genetic evolution in lymphoma Florian Scherer | Freiburg |
| 11:50 | Challenge of Bioinformatics in Liquid Biopsy Hauke Busch | Lübeck |
| 12:10 | Wrap-up and closing remarks |
| Parallel Session 2b | Extracellular vesicles, bioinformatics and emerging technologies Chairs: Timo Gemoll | Lübeck, Florence Schaffner | Strasbourg | |
| 10:50 | Extracellular Vesicles (EVs) Cecile Maire | Hamburg |
| 11:10 | Analyzing EVs from tumor patients – how to separate EVs from other interfering particles in body fluids An Hendrix | Ghent |
| 11:30 | Microfluidics for improving Liquid Biopsy applications Nils Paust | Freiburg |
| 11:50 | Wrap-up and closing remarks |
| 12:20 | The virtual NORD Liquid Biopsy Activity Wall |
| 12:30 | Liquid Biopsy Spotlights - VIDEO LUNCH Break |
| Special Session | Interdisciplinary and transnational research activities Chairs: Catherine Alix-Panabières | Montpellier, Udo Schumacher | Hamburg | |
| 13:00 | The European Liquid Biopsy Society (ELBS) Klaus Pantel | Hamburg |
| 13:15 | The Danish ctDNA network initiative to standardize ctDNA analyses and prospective clinical ctDNA studies Niels Pallisgaard | Roskilde |
| 13:30 | DKTK EXLIQUID – Exploiting liquid biopsies to advance cancer precision medicine Christof Winter | München |
| 13:45 | Liquid Biopsy Trial Activities of the Cancéropôle Est Florence Schaffner | Strasbourg, Alexandre Harlé | Nancy |
| 14:00 | Wrap-up and closing remarks |
| 14:10 | Cookies & Coffee BREAK |
| 14:30 | Keynote Lecture | Liquid Biopsy for early detection and screening: ready for prime time? Nick Papadopoulos | Baltimore Chairs: Nikolas von Bubnoff | Lübeck, Klaus Pantel | Hamburg |
| Session 3 | Clinical Trials and planned projects Chairs: Susanne Sebens | Kiel, Nils Paust | Freiburg | |
| 15:15 | Liquid Biopsy for risk stratification after completion of surgical treatment in GIST and Melanoma Maxim Kebenko | Lübeck |
| 15:30 | ctDNA-guided switch from targeted to immune therapy in metastatic melanoma Christoffer Gebhardt | Hamburg |
| 15:45 | DeteCTC consortium to monitor relapses of breast, ovarian, and pancreatic cancers Dirk Bauerschlag | Kiel |
| 16:00 | Complementary Liquid Biopsy analysis to determine tumor cell heterogeneity in advanced prostate cancer Stefan Werner | Hamburg |
| 16:15 | Wrap-up and closing remarks |
| 16:20 | Liquid Biopsy Spotlight Award Scientific committee |
| 16:45 | Concluding remarks Scientific committee |
Support
In accordance with transparency obligations, we transparently present the services and the extent of support provided by companies to participants both in announcing and holding the congress. LINK